Advertisements



Roche Holding"s (RHHBY) Virtual Late Stage Pipeline Event 2018 - Slideshow

Roche Holding"s (RHHBY) Virtual Late Stage Pipeline Event 2018 - Slideshow.....»»

Category: topSource: seekingalphaSep 14th, 2018

Roche Holding Ltd (RHHBY) Management on Virtual Pipeline Event 2018 World Conference on Lung Cancer Conference Call (Transcript)

Roche Holding Ltd (RHHBY) Management on Virtual Pipeline Event 2018 World Conference on Lung Cancer Conference Call (Transcript).....»»

Category: topSource: seekingalphaSep 26th, 2018

Roche Holding Ltd ADR (RHHBY) CEO Severin Schwan on Q4 2018 Results - Earnings Call Transcript

Roche Holding Ltd ADR (RHHBY) CEO Severin Schwan on Q4 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaFeb 1st, 2019

Roche Holding Ltd (RHHBY) Management Presents at 2018 American Society of Hematology"s 60th Annual Meeting Conference (Transcript)

Roche Holding Ltd (RHHBY) Management Presents at 2018 American Society of Hematology"s 60th Annual Meeting Conference (Transcript).....»»

Category: topSource: seekingalphaDec 5th, 2018

Roche Holding Ltd (RHHBY) CEO Severin Schwan on Q3 2018 Results - Earnings Call Transcript

Roche Holding Ltd (RHHBY) CEO Severin Schwan on Q3 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaOct 18th, 2018

Roche Announces Positive Data on Breast Cancer Drug Kadcyla

Roche's (RHHBY) breast cancer drug Kadcyla, in a late-stage study in patients suffering from HER2-positive eBCmet, met its goal. Roche RHHBY announced encouraging results from a phase III st.....»»

Category: smallbizSource: nytOct 16th, 2018

Roche Holding Ltd ADR (RHHBY) CEO Severin Schwan on Q2 2018 Results - Earnings Call Transcript

Roche Holding Ltd ADR (RHHBY) CEO Severin Schwan on Q2 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaJul 26th, 2018

Roche"s Tecentriq Met Primary Goal in First-Line NSCLC Study

Roche's (RHHBY) late-stage lung cancer study on immuno-oncology drug, Tecentriq, meets its co-primary endpoint of progression-free survival (PFS). Roche H.....»»

Category: dealsSource: nytJul 19th, 2018

Roche Holding ADR (RHHBY) Presents At Deutsche Bank Securities Inc. DbAccess Berlin Conference - Slideshow

Roche Holding ADR (RHHBY) Presents At Deutsche Bank Securities Inc. DbAccess Berlin Conference - Slideshow.....»»

Category: topSource: seekingalphaJun 6th, 2018

Roche Holding"s (RHHBY) CEO Severin Schwan on Q1 2018 Results - Earnings Call Transcript

Roche Holding"s (RHHBY) CEO Severin Schwan on Q1 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaApr 27th, 2018

Alkermes CEO sees 2019 as important year for late-stage pipeline

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 14th, 2019

Pfizer Biopharmaceuticals Group"s Late-Stage Pipeline Looks Well Positioned

Pfizer Biopharmaceuticals Group"s Late-Stage Pipeline Looks Well Positioned.....»»

Category: topSource: seekingalphaFeb 6th, 2019

Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance

Zacks.....»»

Category: topSource: redinewsFeb 1st, 2019

Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance

Roche's (RHHBY) performance in 2018 is driven.....»»

Category: personnelSource: nytFeb 1st, 2019

Roche Holding Ltd ADR 2018 Q4 - Results - Earnings Call Slides

Roche Holding Ltd ADR 2018 Q4 - Results - Earnings Call Slides.....»»

Category: topSource: seekingalphaJan 31st, 2019

Roche Halts Two Late-Stage Studies on Alzheimer"s Candidate

Zacks.....»»

Category: topSource: redinewsJan 30th, 2019

Analysts defend Biogen after Roche discontinues late-stage Alzheimer’s drug trials

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 30th, 2019

Biohaven Pharmaceuticals Reports Third Quarter 2018 Financial And Recent Business Results

NEW HAVEN, Conn., Nov. 14, 2018 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN), a clinical-stage biopharmaceutical comp.....»»

Category: earningsSource: benzingaNov 14th, 2018

Neon Therapeutics Reports Third Quarter 2018 Financial Results and Recent Business Highlights

Data presented at ESMO and SITC underscore continued clinical progress across platform and pipeline CAMBRIDGE, Mass., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (NASDAQ:NTGN), a clinical-stage immuno-oncology compa.....»»

Category: earningsSource: benzingaNov 12th, 2018

Emphasis on unity at Allegheny Conference annual meeting

The late Fred Rogers opened the 2018 annual meeting of the Allegheny Conference on Community Development Thursday night, and on a small screen on the stage of a darkened Carnegie Music Hall in Oakland, he told the short story that has become a mant.....»»

Category: topSource: bizjournalsNov 9th, 2018

PLx Pharma Inc. Reports Third Quarter 2018 Results

PLx has identified the alternate supply of a key ingredient for Vazalore HOUSTON, Nov. 09, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on commerciali.....»»

Category: earningsSource: benzingaNov 9th, 2018